Human Papillomavirus Vaccine

Human Papillomavirus (HPV) Vaccine Update:

The FDA recently approved the use of a new vaccine against human papillomavirus (HPV). HPV is the most commonly sexually transmitted disease in the United States and is responsible for most forms of cervical cancer, and less commonly, vaginal and vulvar cancers in women. While 70-90% of sexually active women may become infected with the virus at some point in her life, only a small percentage of women will actually develop cervical cancer from their infection.

Nonetheless, the ability to prevent transmission of the HPV virus provides us with a unique opportunity to decrease cervical cancer. There are over 100 types of HPV viruses and this vaccine works against four that are most likely to cause cervical cancer. The current recommendations are to give the vaccine to girls ages 9 to 26. It is most effective when given prior to becoming sexually active. Women with known HPV infection, or who have already had precancerous pap smears are not the best candidates for the vaccine. Many medical organizations are currently reviewing these recommendations and there may be some changes to these guidelines in the future.

Use of the HPV vaccine is not meant to condone sexual activity in adolescents, nor is it meant to replace safe sex practices. All women need to be aware of the benefits of abstinence and the importance of using condoms if they choose to become sexually active. As this vaccine is useful against only 4 strains of the virus, there is still uncertainty about its long term effectiveness. For this reason, all women should continue to have pap smears every 1-3 years and yearly pelvic exams.

Currently, this vaccine is available at Clinic Sofia. You should check with your insurance plan to determine if the vaccine will be covered.

For more questions in regards to HPV and the Gardasil shot, click on the link below:

• Gardasil Information